首页 › 基金 › Vivo Capital, LLC › ANIX
Vivo Capital, LLC 对 ANIX 的持仓历史
ANIXA BIOSCIENCES · 医疗保健
Vivo Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 ANIX(ANIXA BIOSCIENCES)877,020 股,市值约 US$28.1M,约占其申报组合的 3.19%,在其申报持仓中市值排名第 12 位。 Vivo Capital, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Vivo Capital, LLC 对 ANIX 的持仓演变
Vivo Capital, LLC 于 Q3 2026 首次披露 ANIX 持仓:877,020 股(约 US$28.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 877.02K | $28.06M | 新进 |
关于 ANIX 与 13F 数据
ANIX(ANIXA BIOSCIENCES)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 ANIX,申报仓位最大的包括:Sanofi (US$63.8M), Remedium Capital Partners, LLC (US$16.6M), Kalehua Capital Management LLC (US$14.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANIX 的基金
- Sanofi 1.99M 股 · $63.81M · Q3 2026
- Remedium Capital Partners, LLC 518.50K 股 · $16.59M · Q3 2026
- Kalehua Capital Management LLC 442.65K 股 · $14.16M · Q3 2026
- NEXTBio Capital Management LP 175.40K 股 · $5.61M · Q3 2026
更多关于 Vivo Capital, LLC
常见问题
How long has Vivo Capital, LLC held ANIX?
Vivo Capital, LLC has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Vivo Capital, LLC's current position in ANIX?
As of Q3 2026, Vivo Capital, LLC holds 877.02K shares of ANIX (ANIXA BIOSCIENCES), valued at $28.06M, representing 3.19% of its reported portfolio and ranking #12.
Has Vivo Capital, LLC been buying or selling ANIX?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in ANIX.
Which other funds hold ANIX?
Other major institutional holders of ANIX include Sanofi, Remedium Capital Partners, LLC, Kalehua Capital Management LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.